ASPADOL 50 Tablet contains Tapentadol Hydrochloride 50 mg, a centrally acting opioid analgesic used for the management of moderate to severe acute pain. Manufactured under strict international quality standards by BLUEPILL EXPRESS, this medication delivers fast-acting and sustained relief in conditions involving neuropathic or musculoskeletal pain. It offers a dual mechanism of action, combining μ-opioid receptor agonism and norepinephrine reuptake inhibition, which makes it an effective alternative to conventional opioids. ASPADOL 50 is trusted by medical professionals across global markets for its efficacy, rapid onset of action, and patient tolerability profile.

This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.

ASPADOL 50 Tablet is an advanced pharmaceutical formulation containing Tapentadol Hydrochloride 50 mg, a powerful centrally acting synthetic analgesic that has redefined the management of acute and chronic pain in clinical practice. Designed for patients suffering from moderate to severe pain, ASPADOL 50 works through a unique dual mechanism that targets pain from both a neurological and nociceptive angle, offering more effective control in a shorter duration. Manufactured by BLUEPILL EXPRESS, a globally recognized third-party pharmaceutical exporter and manufacturer, ASPADOL 50 meets the stringent quality benchmarks set by WHO-GMP, ISO, and various national drug regulatory authorities. It is a preferred solution in both hospital settings and outpatient care globally.

Tapentadol, the active component of ASPADOL 50, is structurally and pharmacologically distinct from traditional opioids like morphine or oxycodone. It combines two synergistic modes of action: μ-opioid receptor agonism and norepinephrine reuptake inhibition. This dual action not only provides strong analgesia but also improves the patient’s functional ability by modulating pain signals at multiple levels of the central nervous system. By engaging both opioid and non-opioid pathways, ASPADOL 50 has been shown to reduce the need for higher opioid doses, thereby lowering the risk of common opioid-induced side effects such as severe respiratory depression, constipation, and dependence.

BLUEPILL EXPRESS has invested extensively in advanced manufacturing infrastructure to ensure the consistent purity, potency, and performance of ASPADOL 50. Each tablet is produced under cleanroom conditions, with comprehensive in-process controls and final quality assessments that adhere to international pharmacopoeial standards. Our manufacturing facilities are certified by WHO-GMP and comply with the regulatory requirements of markets across Latin America, Southeast Asia, Africa, the Middle East, and the CIS regions. Through its global distribution network, BLUEPILL EXPRESS has positioned ASPADOL 50 as a key offering in the field of pain management therapeutics.